| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | RMD | ResMed Common Stock | 6,915 | 01 Jul 2022 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Reflects beneficially owned shares as of July 1, 2022 when Ms. Blaise was appointed as an executive officer. |